Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Colorectal Neoplasms

Free Subscription Articles published in Ann Surg Retrieve available abstracts of 168 articles: HTML format

Single Articles

July 2021
1. LOUGHREY MB, Webster F, Arends MJ, Brown I, et al
   Dataset for Pathology Reporting of Colorectal Cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
   Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93438.
   PubMed     Abstract available
   
   
   May 2021
2. BALVARDI S, Pecorelli N, Castelino T, Niculiseanu P, et al
   Impact of Facilitation of Early Mobilization on Postoperative Pulmonary Outcomes After Colorectal Surgery: A Randomized Controlled Trial.
   Ann Surg. 2021;273:868-875.
   PubMed     Abstract available
   
   
   April 2021
3. KEMENY NE, Chou JF, Capanu M, Chatila WK, et al
   A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy with or without Panitumumab after Hepatic Resection of KRAS Wild-Type Colorectal Cancer.
   Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93567.
   PubMed     Abstract available
   
   
   
4. ONERUP A, Andersson J, Angenete E, Bock D, et al
   Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.
   Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93606.
   PubMed     Abstract available
   
   
   
5. CURTIS NJ, Dennison G, Brown CSB, Hewett PJ, et al
   Clinical Evaluation of Intraoperative Near Misses in Laparoscopic Rectal Cancer Surgery.
   Ann Surg. 2021;273:778-784.
   PubMed     Abstract available
   
   
   March 2021
6. HASSELGREN K, Rosok BI, Larsen PN, Sparrelid E, et al
   ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.
   Ann Surg. 2021;273:442-448.
   PubMed     Abstract available
   
   
   February 2021
7. ISHIBE A, Watanabe J, Ota M, Endo I, et al
   Response to Comments on "A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG1305 (PROBE study)".
   Ann Surg. 2021 Feb 26. doi: 10.1097/SLA.0000000000004824.
   PubMed    
   
   
   
8. CAZELLES A, Manceau G, Taieb J, Karoui M, et al
   Comments On "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed By Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE study)" Ann Surg 2020 [Epub ahead of print]. DOI: 10.1097/SLA.0000000000004
   Ann Surg. 2021 Feb 18. pii: 00000658-900000000-93710.
   PubMed    
   
   
   
9. ZHANG Q, Chen B, Liu ZK
   Comment on "Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer, A Competing Risks Analysis".
   Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93706.
   PubMed    
   
   
   
10. DI BUONO G, Agrusa A
    Response to: Comment on "Feasibility and safety of laparoscopic Complete Mesocolic Excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93705.
    PubMed    
    
    
    
11. LU JY, Xiao Y
    Comment on "Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-term Outcomes. A Randomized Clinical Study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93703.
    PubMed    
    
    
    
12. STEIN SL
    Measure Twice, Cut Once.
    Ann Surg. 2021;273:195-196.
    PubMed    
    
    
    January 2021
13. WATANABE J, Ishibe A, Suwa H, Ota M, et al
    Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer.
    Ann Surg. 2021 Jan 28. doi: 10.1097/SLA.0000000000004252.
    PubMed     Abstract available
    
    
    December 2020
14. HEALY MA, Peacock O, Hu CY, Bednarski BK, et al
    High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004682.
    PubMed     Abstract available
    
    
    
15. OKUGAWA Y, Toiyama Y, Ohi M, Kusunoki M, et al
    Response to the Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
16. KUDOSE Y, Ahiko Y, Shida D
    Response to: Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
17. WANG X, Zheng Z, Chi P
    Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    
    
    
    
18. DENG X, Liu P, Jiang D, Wei M, et al
    Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Ann Surg. 2020;272:1060-1069.
    PubMed     Abstract available
    
    
    
19. YAMASHITA S, Chun YS, Kopetz SE, Maru D, et al
    APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Ann Surg. 2020;272:1080-1085.
    PubMed     Abstract available
    
    
    November 2020
20. POULSON M, Cornell E, Madiedo A, Kenzik K, et al
    The Impact of Racial Residential Segregation on Colorectal Cancer Outcomes and Treatment.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004653.
    PubMed     Abstract available
    
    
    
21. TRILLING B, Delattre F, Faucheron JL
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004403.
    PubMed    
    
    
    
22. GAO Z, Wang C, Jiang K, Shen Z, et al
    Response to the Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results from a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004394.
    PubMed    
    
    
    
23. GAO Z, Wang C, Tao Z, Ye Y, et al
    Response to Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004273.
    PubMed    
    
    
    
24. ZHU D, Xia J, Gu Y, Lin J, et al
    Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-Center, Randomized Controlled Trial.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004558.
    PubMed     Abstract available
    
    
    
25. DI BUONO G, Buscemi S, Cocorullo G, Sorce V, et al
    Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-Term Outcomes. A Randomized Clinical Study.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004557.
    PubMed     Abstract available
    
    
    
26. PETROWSKY H, Linecker M, Raptis DA, Kuemmerli C, et al
    First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases.
    Ann Surg. 2020;272:793-800.
    PubMed     Abstract available
    
    
    
27. IGNATAVICIUS P, Oberkofler CE, Chapman WC, DeMatteo RP, et al
    Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?
    Ann Surg. 2020;272:715-722.
    PubMed     Abstract available
    
    
    
28. AREZZO A, Forcignano E, Bonino MA, Balague C, et al
    Long-term Oncologic Results After Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Left-sided Colonic Obstruction: A Multicenter Randomized Controlled Trial (ESCO Trial).
    Ann Surg. 2020;272:703-708.
    PubMed     Abstract available
    
    
    October 2020
29. GLEASON F, Chu DI, Kennedy GD, Kenzik KM, et al
    Early Elective Surgery After Colon Cancer Diagnosis has Higher Risk of Readmission and Death.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004431.
    PubMed     Abstract available
    
    
    
30. NG KS, Dent OF, Chan C, Newland RC, et al
    Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004353.
    PubMed     Abstract available
    
    
    
31. SOUADKA A, Majbar MA, Essangri H, Benkabbou A, et al
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-Year Results From a Prospective, Nonrandomized, Double-Blind, Controlled Trial".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004284.
    PubMed    
    
    
    September 2020
32. ISHIBE A, Watanabe J, Suwa Y, Nakagawa K, et al
    A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG 1305 (PROBE study).
    Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004494.
    PubMed     Abstract available
    
    
    August 2020
33. VELD JV, Amelung FJ, Borstlap WAA, van Halsema EE, et al
    Decompressing Stoma as Bridge to Elective Surgery is an Effective Strategy for Left-sided Obstructive Colon Cancer: A National, Propensity-score Matched Study.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004173.
    PubMed     Abstract available
    
    
    
34. OKUGAWA Y, Toiyama Y, Yamamoto A, Shigemori T, et al
    Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
    Ann Surg. 2020;272:342-351.
    PubMed     Abstract available
    
    
    
35. O'LEARY MP, Choong KC, Thornblade LW, Fakih MG, et al
    Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.
    Ann Surg. 2020;272:e98-e105.
    PubMed     Abstract available
    
    
    
36. GHOLAMI S, Kemeny NE, Boucher TM, Gonen M, et al
    Adjuvant Hepatic Artery Infusion Chemotherapy is Associated With Improved Survival Regardless of KRAS Mutation Status in Patients With Resected Colorectal Liver Metastases: A Retrospective Analysis of 674 Patients.
    Ann Surg. 2020;272:352-356.
    PubMed     Abstract available
    
    
    
37. SYN NL, Kabir T, Koh YX, Tan HL, et al
    Survival Advantage of Laparoscopic Versus Open Resection For Colorectal Liver Metastases: A Meta-analysis of Individual Patient Data From Randomized Trials and Propensity-score Matched Studies.
    Ann Surg. 2020;272:253-265.
    PubMed     Abstract available
    
    
    July 2020
38. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available
    
    
    
39. YUAN Z, Xu T, Cai J, Zhao Y, et al
    Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer.
    Ann Surg. 2020 Jul 16. doi: 10.1097/SLA.0000000000004229.
    PubMed     Abstract available
    
    
    
40. SAO JULIAO GP, Karagkounis G, Fernandez LM, Habr-Gama A, et al
    Conditional Survival in Patients With Rectal Cancer and Complete Clinical Response Managed by Watch and Wait After Chemoradiation: Recurrence Risk Over Time.
    Ann Surg. 2020;272:138-144.
    PubMed     Abstract available
    
    
    June 2020
41. KUDOSE Y, Shida D, Ahiko Y, Nakamura Y, et al
    Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort.
    Ann Surg. 2020 Jun 11. doi: 10.1097/SLA.0000000000004058.
    PubMed     Abstract available
    
    
    
42. ZHANG QX, Xu BB, Xue Z
    Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020 Jun 4. doi: 10.1097/SLA.0000000000003856.
    PubMed    
    
    
    
43. DEERY SE, Cavallaro PM, McWalters ST, Reilly SR, et al
    Colorectal Surgical Site Infection Prevention Kits Prior to Elective Colectomy Improve Outcomes.
    Ann Surg. 2020;271:1110-1115.
    PubMed     Abstract available
    
    
    May 2020
44. O'LEARY MP, Choong KC, Thornblade LW, Fakih MG, et al
    Management Considerations for the Surgical Treatment of Colorectal Cancer During the Global Covid-19 Pandemic.
    Ann Surg. 2020 May 22. doi: 10.1097/SLA.0000000000004029.
    PubMed     Abstract available
    
    
    
45. AZOULAY D, Lim C
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": Shaking the Coconut Tree.
    Ann Surg. 2020;271:e122-e124.
    PubMed    
    
    
    
46. DUELAND S, Line PD
    Response to the Comment on"Survival Following Liver Transplantation for Patients With Non-resectable Liver Only Colorectal Metastases": What if those Lesions Are Gone?
    Ann Surg. 2020;271:e124.
    PubMed    
    
    
    April 2020
47. KAROUI M, Rullier A, Piessen G, Legoux JL, et al
    Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).
    Ann Surg. 2020;271:637-645.
    PubMed     Abstract available
    
    
    
48. BLOK RD, Hagemans JAW, Klaver CEL, Hellinga J, et al
    A Systematic Review and Meta-analysis on Omentoplasty for the Management of Abdominoperineal Defects in Patients Treated for Cancer.
    Ann Surg. 2020;271:654-662.
    PubMed     Abstract available
    
    
    
49. HASAN S, Renz P, Wegner RE, Finley G, et al
    Microsatellite Instability (MSI) as an Independent Predictor of Pathologic Complete Response (PCR) in Locally Advanced Rectal Cancer: A National Cancer Database (NCDB) Analysis.
    Ann Surg. 2020;271:716-723.
    PubMed     Abstract available
    
    
    March 2020
50. BOUDJEMA K, Locher C, Sabbagh C, Ortega-Deballon P, et al
    Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003848.
    PubMed     Abstract available
    
    
    
51. LEE YS, Kim JH, Kim HJ, Lee SC, et al
    Short-term Outcomes of Single-port Versus Multiport Laparoscopic Surgery for Colon Cancer: The SIMPLE Multicenter Randomized Clinical Trial.
    Ann Surg. 2020 Mar 20. doi: 10.1097/SLA.0000000000003882.
    PubMed     Abstract available
    
    
    
52. RONNOW CF, Arthursson V, Toth E, Krarup PM, et al
    Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation.
    Ann Surg. 2020 Mar 13. doi: 10.1097/SLA.0000000000003854.
    PubMed     Abstract available
    
    
    
53. PETRELLI F, Trevisan F, Cabiddu M, Sgroi G, et al
    Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
    Ann Surg. 2020;271:440-448.
    PubMed     Abstract available
    
    
    February 2020
54. SABBAGH C, Manceau G, Mege D, Abdalla S, et al
    Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database.
    Ann Surg. 2020 Feb 14. doi: 10.1097/SLA.0000000000003832.
    PubMed     Abstract available
    
    
    
55. CHUN YS, Vauthey JN
    Response to Comment on "Deleterious Effect of RAS and Evolutionary High Risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e16-e17.
    PubMed    
    
    
    
56. WARD J, Soonawalla Z, Silva M
    Comment on "Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e15-e16.
    PubMed    
    
    
    
57. ZHAO X, Wang C, Li Z
    Comment on "Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases".
    Ann Surg. 2020;271:e16.
    PubMed    
    
    
    January 2020
58. AHL R, Matthiessen P, Fang X, Cao Y, et al
    beta-Blockade in Rectal Cancer Surgery: A Simple Measure of Improving Outcomes.
    Ann Surg. 2020;271:140-146.
    PubMed     Abstract available
    
    
    
59. GAGNIERE J, Dupre A, Gholami SS, Pezet D, et al
    Is Hepatectomy Justified for BRAF Mutant Colorectal Liver Metastases?: A Multi-institutional Analysis of 1497 Patients.
    Ann Surg. 2020;271:147-154.
    PubMed     Abstract available
    
    
    December 2019
60. KALTENMEIER C, Shen C, Medich DS, Geller DA, et al
    Time to Surgery and Colon Cancer Survival in the United States.
    Ann Surg. 2019 Dec 10. doi: 10.1097/SLA.0000000000003745.
    PubMed     Abstract available
    
    
    
61. ROSEN CB, Nagorney DM, Alberts SR
    Is There a Role for Liver Transplantation in the Treatment of Patients With Metastatic Colorectal Cancer?
    Ann Surg. 2019 Dec 5. doi: 10.1097/SLA.0000000000003713.
    PubMed    
    
    
    
62. ACUNA SA, Chesney TR, Baxter NN
    Response to Comment on "Routine Use of Laparoscopic Surgery for Rectal Cancer".
    Ann Surg. 2019;270:e146-e147.
    PubMed    
    
    
    
63. CHEN HL, Song YP, Liu K
    Comment on "Routine Use of Laparoscopic Surgery for Rectal Cancer".
    Ann Surg. 2019;270:e145-e146.
    PubMed    
    
    
    
64. KANEMOTO Y, Kurokawa T, Tanimoto T
    Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".
    Ann Surg. 2019;270:e118-e119.
    PubMed    
    
    
    
65. HABR-GAMA A, Sao Juliao GP, Vailati BB, Fernandez LM, et al
    Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?"
    Ann Surg. 2019;270:e119-e120.
    PubMed    
    
    
    
66. D'SOUZA N, de Neree Tot Babberich MPM, d'Hoore A, Tiret E, et al
    Definition of the Rectum: An International, Expert-based Delphi Consensus.
    Ann Surg. 2019;270:955-959.
    PubMed     Abstract available
    
    
    
67. GUERRA F, Giuliani G
    Comment on "Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial".
    Ann Surg. 2019;270:e103-e104.
    PubMed    
    
    
    
68. DORCARATTO D, Mazzinari G, Fernandez M, Munoz E, et al
    Impact of Postoperative Complications on Survival and Recurrence After Resection of Colorectal Liver Metastases: Systematic Review and Meta-analysis.
    Ann Surg. 2019;270:1018-1027.
    PubMed     Abstract available
    
    
    
69. FUJITA S
    Response to Comment on "Letter to the Editor".
    Ann Surg. 2019;270:e81-e82.
    PubMed    
    
    
    
70. CIROCCHI R, Graziosi L, D'Andrea V, Popivanov GI, et al
    Comment on "Is the Routine Dissection of Lateral Lymph Nodes Really Necessary After Mesorectal Excision for Clinical Stage II/III Lower Rectal Cancer?"
    Ann Surg. 2019;270:e80-e81.
    PubMed    
    
    
    
71. LEE L, de Lacy B, Gomez Ruiz M, Liberman AS, et al
    A Multicenter Matched Comparison of Transanal and Robotic Total Mesorectal Excision for Mid and Low-rectal Adenocarcinoma.
    Ann Surg. 2019;270:1110-1116.
    PubMed     Abstract available
    
    
    November 2019
72. ROODBEEN SX, de Lacy FB, van Dieren S, Penna M, et al
    Predictive Factors and Risk Model for Positive Circumferential Resection Margin Rate After Transanal Total Mesorectal Excision in 2653 Patients With Rectal Cancer.
    Ann Surg. 2019;270:884-891.
    PubMed     Abstract available
    
    
    
73. LANG H, Baumgart J, Heinrich S, Tripke V, et al
    Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases.
    Ann Surg. 2019;270:799-805.
    PubMed     Abstract available
    
    
    
74. LEFEVRE JH, Mineur L, Cachanado M, Denost Q, et al
    Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
    Ann Surg. 2019;270:747-754.
    PubMed     Abstract available
    
    
    
75. RAPTIS DA, Linecker M, Kambakamba P, Tschuor C, et al
    Defining Benchmark Outcomes for ALPPS.
    Ann Surg. 2019;270:835-841.
    PubMed     Abstract available
    
    
    
76. ALLAIX ME, Degiuli M, Bonino MA, Arezzo A, et al
    Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy: A Double-blinded Randomized Controlled Trial.
    Ann Surg. 2019;270:762-767.
    PubMed     Abstract available
    
    
    
77. TSAI AY, Mavroveli S, Miskovic D, van Oostendorp S, et al
    Surgical Quality Assurance in COLOR III: Standardization and Competency Assessment in a Randomized Controlled Trial.
    Ann Surg. 2019;270:768-774.
    PubMed     Abstract available
    
    
    September 2019
78. FENTON HM, Taylor JC, Lodge JPA, Toogood GJ, et al
    Variation in the Use of Resection for Colorectal Cancer Liver Metastases.
    Ann Surg. 2019 Sep 16. doi: 10.1097/SLA.0000000000003534.
    PubMed     Abstract available
    
    
    August 2019
79. RAOOF M, Haye S, Ituarte PHG, Fong Y, et al
    Liver Resection Improves Survival in Colorectal Cancer Patients: Causal-Effects From Population-Level Instrumental Variable Analysis.
    Ann Surg. 2019 Aug 29. doi: 10.1097/SLA.0000000000003485.
    PubMed     Abstract available
    
    
    
80. GAO Z, Wang C, Zhan S, Tao Z, et al
    Response to Comment on "Controlling for Ascertainment Bias May Introduce Control Group Bias in Prospective Nonrandomized Trials".
    Ann Surg. 2019;270:e55.
    PubMed    
    
    
    
81. SIMILLIS C, Tekkis PP
    Comment on "Robotic Versus Laparoscopic Surgery for Rectal Cancer: An Evidence-based Approach".
    Ann Surg. 2019;270:e57.
    PubMed    
    
    
    
82. PRETE FP, Prete F, Strippoli GFM
    Response to Comment on "Robotic Versus Laparoscopic Surgery for Rectal Cancer: An Evidence-based Approach".
    Ann Surg. 2019;270:e57-e58.
    PubMed    
    
    
    
83. GACHABAYOV M, Dyatlov A, Bergamaschi R
    Comment on "Controlling for Ascertainment Bias May Introduce Control Group Bias in Prospective Nonrandomized Trials".
    Ann Surg. 2019;270:e54-e55.
    PubMed    
    
    
    
84. MARTINEZ-PEREZ A, de'Angelis N
    Comment on "Mid-term Results of ACOSOG Z6051 Trial Sustain the Unresolved Debate".
    Ann Surg. 2019;270:e52-e53.
    PubMed    
    
    
    
85. FLESHMAN J
    Response to Comment on "Letter to the Editor for Z6051 (Revised 11/14/18)".
    Ann Surg. 2019;270:e53-e54.
    PubMed    
    
    
    
86. BIONDI A, Persiani R
    Comment on "Distal Resection Margin Status in Transanal Total Mesorectal Excision (TA-TME)".
    Ann Surg. 2019;270:e34-e35.
    PubMed    
    
    
    
87. SANDSTROM P, Larsson AL, Bjornsson B, Rosok BI, et al
    Response to Comment on "When Innovation Is Not Enough".
    Ann Surg. 2019;270:e36-e37.
    PubMed    
    
    
    
88. VEGA EA, Simoneau E, Tzeng CD, Odisio BC, et al
    Comment on Letter to the Editor Regarding "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: When Innovation is Not Enough".
    Ann Surg. 2019;270:e35-e36.
    PubMed    
    
    
    
89. HAUSKEN J, Fretland AA, Edwin B, Andersen MH, et al
    Intravenous Patient-controlled Analgesia Versus Thoracic Epidural Analgesia After Open Liver Surgery: A Prospective, Randomized, Controlled, Noninferiority Trial.
    Ann Surg. 2019;270:193-199.
    PubMed     Abstract available
    
    
    July 2019
90. JONES EL, Halpern AL, Carmichael H, Wikiel KJ, et al
    Hepatic Ablation Promotes Colon Cancer Metastases in an Immunocompetent Murine Model.
    Ann Surg. 2019 Jul 23. doi: 10.1097/SLA.0000000000003474.
    PubMed     Abstract available
    
    
    
91. TREPANIER M, Minnella EM, Paradis T, Awasthi R, et al
    Improved Disease-Free Survival After Prehabilitation for Colorectal Cancer Surgery.
    Ann Surg. 2019 Jul 15. doi: 10.1097/SLA.0000000000003465.
    PubMed     Abstract available
    
    
    
92. FAUCHERON JL, Sage PY, Trilling B
    Comment on "What Expert Surgeons Never Tell You About Robot-assisted Surgery for Rectal Cancer?"
    Ann Surg. 2019;270:e10-e11.
    PubMed    
    
    
    
93. SIMILLIS C, Lal N, Thoukididou SN, Kontovounisios C, et al
    Open Versus Laparoscopic Versus Robotic Versus Transanal Mesorectal Excision for Rectal Cancer: A Systematic Review and Network Meta-analysis.
    Ann Surg. 2019;270:59-68.
    PubMed     Abstract available
    
    
    June 2019
94. RASKOV H, Soby JH, Troelsen J, Bojesen RD, et al
    Driver Gene Mutations and Epigenetics in Colorectal Cancer.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003393.
    PubMed     Abstract available
    
    
    
95. DUELAND S, Syversveen T, Solheim JM, Solberg S, et al
    Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases.
    Ann Surg. 2019 Jun 7. doi: 10.1097/SLA.0000000000003404.
    PubMed     Abstract available
    
    
    
96. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    Prognostic Factors Change Over Time After Hepatectomy for Colorectal Liver Metastases: A Multi-institutional, International Analysis of 1099 Patients.
    Ann Surg. 2019;269:1129-1137.
    PubMed     Abstract available
    
    
    
97. JUUL T, Elfeki H, Christensen P, Laurberg S, et al
    Normative Data for the Low Anterior Resection Syndrome Score (LARS Score).
    Ann Surg. 2019;269:1124-1128.
    PubMed     Abstract available
    
    
    
98. KARAGKOUNIS G, Thai L, Mace AG, Wiland H, et al
    Prognostic Implications of Pathological Response to Neoadjuvant Chemoradiation in Pathologic Stage III Rectal Cancer.
    Ann Surg. 2019;269:1117-1123.
    PubMed     Abstract available
    
    
    
99. MARI GM, Crippa J, Cocozza E, Berselli M, et al
    Low Ligation of Inferior Mesenteric Artery in Laparoscopic Anterior Resection for Rectal Cancer Reduces Genitourinary Dysfunction: Results From a Randomized Controlled Trial (HIGHLOW Trial).
    Ann Surg. 2019;269:1018-1024.
    PubMed     Abstract available
    
    
    May 2019
100. VAN PRAAGH JB, de Goffau MC, Harmsen HJM, Havenga K, et al
     Response to Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
     Ann Surg. 2019;269:e69-e70.
     PubMed    
     
     
     
101. LAMENDELLA R, Stewart DB
     Comment on "Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage".
     Ann Surg. 2019;269:e68-e69.
     PubMed    
     
     
     
102. PARC Y, Ruppert R, Fuerst A, Golcher H, et al
     Better Function With a Colonic J-Pouch or a Side-to-end Anastomosis?: A Randomized Controlled Trial to Compare the Complications, Functional Outcome, and Quality of Life in Patients With Low Rectal Cancer After a J-Pouch or a Side-to-end Anastomosis.
     Ann Surg. 2019;269:815-826.
     PubMed     Abstract available
     
     
     
103. ACUNA SA, Chesney TR, Ramjist JK, Shah PS, et al
     Laparoscopic Versus Open Resection for Rectal Cancer: A Noninferiority Meta-analysis of Quality of Surgical Resection Outcomes.
     Ann Surg. 2019;269:849-855.
     PubMed     Abstract available
     
     
     
104. MARTI WR, Curti G, Wehrli H, Grieder F, et al
     Clinical Outcome After Rectal Replacement With Side-to-End, Colon-J-Pouch, or Straight Colorectal Anastomosis Following Total Mesorectal Excision: A Swiss Prospective, Randomized, Multicenter Trial (SAKK 40/04).
     Ann Surg. 2019;269:827-835.
     PubMed     Abstract available
     
     
     
105. CHUN YS, Passot G, Yamashita S, Nusrat M, et al
     Deleterious Effect of RAS and Evolutionary High-risk TP53 Double Mutation in Colorectal Liver Metastases.
     Ann Surg. 2019;269:917-923.
     PubMed     Abstract available
     
     
     April 2019
106. MARGONIS GA, Andreatos N, Wolfgang CL, Weiss MJ, et al
     Response to the Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
     Ann Surg. 2019;269:e49-e51.
     PubMed    
     
     
     
107. VIGANO L, Costa G, Toso C, Cimino M, et al
     Comment on "Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases."
     Ann Surg. 2019;269:e47-e49.
     PubMed    
     
     
     
108. MATHIS KL, Nelson H
     Laparoscopic Proctectomy for Cancer.
     Ann Surg. 2019;269:603-604.
     PubMed    
     
     
     
109. STEVENSON ARL, Solomon MJ, Brown CSB, Lumley JW, et al
     Disease-free Survival and Local Recurrence After Laparoscopic-assisted Resection or Open Resection for Rectal Cancer: The Australasian Laparoscopic Cancer of the Rectum Randomized Clinical Trial.
     Ann Surg. 2019;269:596-602.
     PubMed     Abstract available
     
     
     
110. FLESHMAN J, Branda ME, Sargent DJ, Boller AM, et al
     Disease-free Survival and Local Recurrence for Laparoscopic Resection Compared With Open Resection of Stage II to III Rectal Cancer: Follow-up Results of the ACOSOG Z6051 Randomized Controlled Trial.
     Ann Surg. 2019;269:589-595.
     PubMed     Abstract available
     
     
     
111. JANG JH, Kim HC, Huh JW, Park YA, et al
     Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer.
     Ann Surg. 2019;269:678-685.
     PubMed     Abstract available
     
     
     March 2019
112. GIGLIO MC, Troisi RI
     Comment on "ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis".
     Ann Surg. 2019;269:e32.
     PubMed    
     
     
     February 2019
113. OKUGAWA Y, Toiyama Y, Yamamoto A, Shigemori T, et al
     Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer.
     Ann Surg. 2019 Feb 16. doi: 10.1097/SLA.0000000000003239.
     PubMed     Abstract available
     
     
     
114. 
     Surgical and Survival Outcomes Following Pelvic Exenteration for Locally Advanced Primary Rectal Cancer: Results From an International Collaboration.
     Ann Surg. 2019;269:315-321.
     PubMed     Abstract available
     
     
     
115. IMAI K, Benitez CC, Allard MA, Vibert E, et al
     Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome.
     Ann Surg. 2019;269:322-330.
     PubMed     Abstract available
     
     
     January 2019
116. SERENARI M, Ardiles V, Ravaioli M, Cescon M, et al
     Rapid but not Harmful: Functional Evaluation With Hepatobiliary Scintigraphy After Accelerated Liver Regeneration Techniques.
     Ann Surg. 2019 Jan 3. doi: 10.1097/SLA.0000000000003184.
     PubMed    
     
     
     
117. SANDSTROM P, Rosok BI, Sparrelid E, Larsen PN, et al
     Response to "ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases".
     Ann Surg. 2019;269:e16-e17.
     PubMed    
     
     
     
118. GIULIANTE F, Ardito F
     ALPPS Versus Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastases.
     Ann Surg. 2019;269:e15-e16.
     PubMed    
     
     
     
119. MARGONIS GA, Andreatos N, Wolfgang CL, Weiss MJ, et al
     Reply to: "Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection".
     Ann Surg. 2019;269:e4-e5.
     PubMed    
     
     
     
120. JI GW, Wang K, Xia YX, Li XC, et al
     Decoding Tumor Biology of Colorectal Liver Metastases With Radiogenomics: A Novel Insight Into Surgical Approach Selection.
     Ann Surg. 2019;269:e3-e4.
     PubMed    
     
     
     
121. PETERSSON J, Koedam TW, Bonjer HJ, Andersson J, et al
     Bowel Obstruction and Ventral Hernia After Laparoscopic Versus Open Surgery for Rectal Cancer in A Randomized Trial (COLOR II).
     Ann Surg. 2019;269:53-57.
     PubMed     Abstract available
     
     
     
122. HABR-GAMA A, Sao Juliao GP, Vailati BB, Sabbaga J, et al
     Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy: The Impact of Radiation Therapy Dose-escalation and Consolidation Chemotherapy.
     Ann Surg. 2019;269:102-107.
     PubMed     Abstract available
     
     
     
123. SUNG SY, Jang HS, Kim SH, Jeong JU, et al
     Oncologic Outcome and Morbidity in the Elderly Rectal Cancer Patients After Preoperative Chemoradiotherapy and Total Mesorectal Excision: A Multi-institutional and Case-matched Control Study.
     Ann Surg. 2019;269:108-113.
     PubMed     Abstract available
     
     
     
124. BRUDVIK KW, Jones RP, Giuliante F, Shindoh J, et al
     RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases.
     Ann Surg. 2019;269:120-126.
     PubMed     Abstract available
     
     
     December 2018
125. NADALIN S, Capobianco I, Koenigsrainer A
     Response: "RAPID but Not Harmful: Functional Evaluation With Hepatobiliary Scintigraphy After Accelerated Liver Regeneration Techniques".
     Ann Surg. 2018 Dec 29. doi: 10.1097/SLA.0000000000003185.
     PubMed    
     
     
     November 2018
126. FAUCHERON JL, Girard E, Trilling B
     Impact of the Primary Tumor Location on the Prognosis for Colon Cancer: Adjustment for Bias Could Lead to Other Conclusions.
     Ann Surg. 2018 Nov 22. doi: 10.1097/SLA.0000000000003099.
     PubMed    
     
     
     August 2018
127. GAO Z, Wang C, Cui Y, Shen Z, et al
     Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial.
     Ann Surg. 2018 Aug 24. doi: 10.1097/SLA.0000000000003012.
     PubMed     Abstract available
     
     
     
128. BHANGU JS, Beer A, Mittlbock M, Tamandl D, et al
     Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
     Ann Surg. 2018 Aug 3. doi: 10.1097/SLA.0000000000002901.
     PubMed     Abstract available
     
     
     July 2018
129. YUN L, Zhiwei J, Kehlet H, Gang W, et al
     Is an Extensive ERAS Program Able to Bring a Better Outcome in Contrast With Standard ERAS Program for Laparoscopic Colorectal Cancer Surgery?
     Ann Surg. 2018 Jul 2. doi: 10.1097/SLA.0000000000002848.
     PubMed    
     
     
     May 2018
130. RENAUD S, Seitlinger J, Lawati YA, Guerrera F, et al
     Anatomical Resections Improve Survival Following Lung Metastasectomy of Colorectal Cancer Harboring KRAS Mutations.
     Ann Surg. 2018 May 17. doi: 10.1097/SLA.0000000000002829.
     PubMed     Abstract available
     
     
     April 2018
131. VALLANCE AE, Keller DS, Hill J, Braun M, et al
     Role of Emergency Laparoscopic Colectomy for Colorectal Cancer: A Population-Based Study in England.
     Ann Surg. 2018 Apr 4. doi: 10.1097/SLA.0000000000002752.
     PubMed     Abstract available
     
     
     
132. STOMMEL MWJ, Ten Broek RPG, Strik C, Slooter GD, et al
     Multicenter Observational Study of Adhesion Formation After Open-and Laparoscopic Surgery for Colorectal Cancer.
     Ann Surg. 2018;267:743-748.
     PubMed     Abstract available
     
     
     March 2018
133. ZHANG K, Chen L
     A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity.
     Ann Surg. 2018;267:e57-e58.
     PubMed    
     
     
     
134. YAMASHITA S, Brudvik KW, Kopetz SE, Maru D, et al
     Embryonic Origin of Primary Colon Cancer Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colon Cancer Liver Metastases.
     Ann Surg. 2018;267:514-520.
     PubMed     Abstract available
     
     
     
135. SAMMOUR T, Malakorn S, Bednarski BK, Kaur H, et al
     Oncological Outcomes After Robotic Proctectomy for Rectal Cancer: Analysis of a Prospective Database.
     Ann Surg. 2018;267:521-526.
     PubMed     Abstract available
     
     
     
136. SUZUKI Y, Okabayashi K, Hasegawa H, Tsuruta M, et al
     Comparison of Preoperative Inflammation-based Prognostic Scores in Patients With Colorectal Cancer.
     Ann Surg. 2018;267:527-531.
     PubMed     Abstract available
     
     
     February 2018
137. BEPPU T, Yamamoto M
     Laparoscopic Versus Open Liver Resection for Colorectal Liver Metastases-Which Is a More Suitable Standard Practice?
     Ann Surg. 2018;267:208-209.
     PubMed    
     
     
     
138. TURNER MC, Adam MA, Sun Z, Kim J, et al
     Response to Letter: Comment on "Insurance Status, Not Race Is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer".
     Ann Surg. 2018;267:e30.
     PubMed    
     
     
     
139. GABRIEL E, Al-Sukhni E, Nurkin S
     Commentary on "Insurance Status, Not Race, is Associated With Use of Minimally Invasive Surgical Approach for Rectal Cancer".
     Ann Surg. 2018;267:e29-e30.
     PubMed    
     
     
     
140. GIACCAGLIA V, Antonelli MS, Salvi PF, Nigri G, et al
     CRP Predicts Safe Patient Discharge After Colorectal Surgery: Reply.
     Ann Surg. 2018;267:e33-e34.
     PubMed    
     
     
     
141. DUPRE A, Gagniere J, Samba H, Rivoire M, et al
     CRP Predicts Safe Patient Discharge After Colorectal Surgery.
     Ann Surg. 2018;267:e33.
     PubMed    
     
     
     
142. FRETLAND AA, Dagenborg VJ, Bjornelv GMW, Kazaryan AM, et al
     Laparoscopic Versus Open Resection for Colorectal Liver Metastases: The OSLO-COMET Randomized Controlled Trial.
     Ann Surg. 2018;267:199-207.
     PubMed     Abstract available
     
     
     
143. KIM MJ, Park SC, Park JW, Chang HJ, et al
     Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer: A Phase II Open Label Prospective Randomized Controlled Trial.
     Ann Surg. 2018;267:243-251.
     PubMed     Abstract available
     
     
     
144. BUCHLI C, Martling A, Abani MA, Frodin JE, et al
     Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study.
     Ann Surg. 2018;267:326-331.
     PubMed     Abstract available
     
     
     January 2018
145. SASAKI K, Morioka D, Conci S, Margonis GA, et al
     The Tumor Burden Score: A New "Metro-ticket" Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors.
     Ann Surg. 2018;267:132-141.
     PubMed     Abstract available
     
     
     December 2017
146. YAMASHITA S, Sheth RA, Niekamp AS, Aloia TA, et al
     Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status.
     Ann Surg. 2017;266:1045-1054.
     PubMed     Abstract available
     
     
     
147. CHI P, Chen Z, Lu X
     Transanal Total Mesorectal Excision: Can it Achieve the Standard of TME?
     Ann Surg. 2017;266:e87-e88.
     PubMed    
     
     
     
148. SMITH FM, Rooney P, Farrell C
     Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
     Ann Surg. 2017;266:e104-e105.
     PubMed    
     
     
     
149. BATTERSBY NJ, Moran B, Stelzner S, West NP, et al
     Reply to: Does MRI Restaging of Rectal Cancer After Chemoradiotherapy Actually Permit a Change in Surgical Management?
     Ann Surg. 2017;266:e116-e118.
     PubMed    
     
     
     
150. MONSON JRT, Arsalanizadeh R
     Transanal Total Mesorectal Excision (TaTME) and Quality of Rectal Cancer Surgery: Do we Really Know?
     Ann Surg. 2017;266:e88-e89.
     PubMed    
     
     
     November 2017
151. MARKAR SR, Chin ST, Romano A, Wiggins T, et al
     Breath Volatile Organic Compound Profiling of Colorectal Cancer Using Selected Ion Flow-Tube Mass Spectrometry.
     Ann Surg. 2017 Nov 29. doi: 10.1097/SLA.0000000000002539.
     PubMed     Abstract available
     
     
     
152. MAGGIORI L, Rullier E, Lefevre JH, Regimbeau JM, et al
     Does a Combination of Laparoscopic Approach and Full Fast Track Multimodal Management Decrease Postoperative Morbidity?: A Multicenter Randomized Controlled Trial.
     Ann Surg. 2017;266:729-737.
     PubMed     Abstract available
     
     
     
153. LINECKER M, Bjornsson B, Stavrou GA, Oldhafer KJ, et al
     Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity.
     Ann Surg. 2017;266:779-786.
     PubMed     Abstract available
     
     
     
154. BORSTLAP WAA, Westerduin E, Aukema TS, Bemelman WA, et al
     Anastomotic Leakage and Chronic Presacral Sinus Formation After Low Anterior Resection: Results From a Large Cross-sectional Study.
     Ann Surg. 2017;266:870-877.
     PubMed     Abstract available
     
     
     
155. VELLINGA TT, Kranenburg O, Frenkel N, Ubink I, et al
     Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
     Ann Surg. 2017;266:765-771.
     PubMed     Abstract available
     
     
     October 2017
156. RAHBARI NN, Carr PR, Jansen L, Chang-Claude J, et al
     Time of Metastasis and Outcome in Colorectal Cancer.
     Ann Surg. 2017 Oct 23. doi: 10.1097/SLA.0000000000002564.
     PubMed     Abstract available
     
     
     
157. KELLEY KA, Ruhl RA, Rana SR, Dewey E, et al
     Understanding and Resetting Radiation Sensitivity in Rectal Cancer.
     Ann Surg. 2017;266:610-616.
     PubMed     Abstract available
     
     
     
158. MARGONIS GA, Buettner S, Andreatos N, Sasaki K, et al
     Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases.
     Ann Surg. 2017;266:641-649.
     PubMed     Abstract available
     
     
     
159. SUJATHA-BHASKAR S, Jafari MD, Gahagan JV, Inaba CS, et al
     Defining the Role of Minimally Invasive Proctectomy for Locally Advanced Rectal Adenocarcinoma.
     Ann Surg. 2017;266:574-581.
     PubMed     Abstract available
     
     
     August 2017
160. SAMMOUR T, Chang GJ
     Lateral Node Dissection in Low Rectal Cancer: Time for a Global Approach?
     Ann Surg. 2017;266:208-209.
     PubMed    
     
     
     April 2017
161. ZHOU H, Ruan C, Hu Z
     Perineal Transanal Approach for Laparoscopic Sphincter-saving Resection in Low Rectal Cancer.
     Ann Surg. 2017;265:e32-e33.
     PubMed    
     
     
     
162. SMITH FM, Winter D
     Pathologic Complete Response of Primary Tumor Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-term Outcomes and Prognostic Significance of Pathologic Nodal Status (KROG 09-01).
     Ann Surg. 2017;265:e27-e28.
     PubMed    
     
     
     
163. RAPTIS DA, Bachler T, Nocito A, Bueter M, et al
     Obesity Surgery and the Risk of Colorectal Carcinoma-Searching for the Fly in the Ointment?
     Ann Surg. 2017;265:e29-e30.
     PubMed    
     
     
     
164. RUI YY, Zhou ZG, Wang C, Yang L, et al
     Are We Ready for Extralevatory Abdominoperineal Excision?
     Ann Surg. 2017;265:e55-e56.
     PubMed    
     
     
     
165. EVRARD S, Poston G
     Response to Faitot et al "Two-stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases: A Case-matched Analysis of Surgical and Oncological Outcomes".
     Ann Surg. 2017;265:e52-e53.
     PubMed    
     
     
     
166. CHEN WH, Luo SL, Kang L
     Transanal Total Mesorectal Excision: Will It Be A Valid Alternative in Rectal Cancer Surgery?
     Ann Surg. 2017;265:e36-e37.
     PubMed    
     
     
     March 2017
167. MISE Y, Hasegawa K, Satou S, Shindoh J, et al
     How Has Virtual Hepatectomy Changed the Practice of Liver Surgery?: Experience of 1194 Virtual Hepatectomy Before Liver Resection and Living Donor Liver Transplantation.
     Ann Surg. 2017 Mar 10. doi: 10.1097/SLA.0000000000002213.
     PubMed     Abstract available
     
     
     January 2017
168. KALADY MF
     Seeing the Trees For the Forest: Rectal Cancer Intratumoral Heterogeneity.
     Ann Surg. 2017;265:e7.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Colorectal Neoplasms is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: